Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Asset Writedowns and Impairment: 2020-2025

Historic Asset Writedowns and Impairment for Beauty Health (SKIN) over the last 5 years, with Sep 2025 value amounting to $1.2 million.

  • Beauty Health's Asset Writedowns and Impairment fell 65.74% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year decrease of 69.11%. This contributed to the annual value of $28.0 million for FY2024, which is 53.46% up from last year.
  • According to the latest figures from Q3 2025, Beauty Health's Asset Writedowns and Impairment is $1.2 million, which was down 33.01% from $1.7 million recorded in Q2 2025.
  • Beauty Health's 5-year Asset Writedowns and Impairment high stood at $13.8 million for Q2 2024, and its period low was -$556,000 during Q4 2022.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $3.4 million (2024), whereas its average is $4.5 million.
  • The largest annual percentage gain for Beauty Health's Asset Writedowns and Impairment in the last 5 years was 3,415.79% (2022), contrasted with its biggest fall of 247.87% (2022).
  • Over the past 5 years, Beauty Health's Asset Writedowns and Impairment (Quarterly) stood at $376,000 in 2021, then slumped by 247.87% to -$556,000 in 2022, then surged by 1,245.14% to $6.4 million in 2023, then dropped by 16.18% to $5.3 million in 2024, then slumped by 65.74% to $1.2 million in 2025.
  • Its Asset Writedowns and Impairment was $1.2 million in Q3 2025, compared to $1.7 million in Q2 2025 and $739,000 in Q1 2025.